Related Experiment Video
Updated: Feb 4, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Timing of Glucocorticoid Treatment Dictates Glucocorticoid Receptor Actions Modulating the NLRP3-Inflammasome
David Diaz-Jimenez1, Robert H Oakley1, Jackson A Hoffman2
1Molecular Endocrinology Group, Molecular and Cellular Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Research Triangle Park, North Carolina, USA.
Abstract:
Glucocorticoids (GCs) are lifesaving medicines prescribed to treat inflammatory diseases. Macrophages play a pivotal role during hyperinflammation and cytokine storm, two processes intricately linked to NLRP3 inflammasome activation. Macrophages undergo a process of transcriptional reprogramming to resolve inflammation and restore homeostasis. We hypothesized that glucocorticoid receptor (GR) signaling contributes to macrophage metabolic reprogramming to overcome the NLRP3-inflammasome activation through genomic effects induced by GCs. Glucocorticoid administration following prolonged exposure to lipopolysaccharide (LPS) decreases the expression of iNOS and ACOD1 and their respective metabolic products, nitric oxide and itaconate, to maintain an intact tricarboxylic acid (TCA) cycle in WT mouse pro-inflammatory macrophages. Glucocorticoids also antagonize the LPS-induced glycolytic switch through their regulation of mitochondrial dynamics. In addition, we show that glucocorticoids inhibit NLRP3 inflammasome activation and subsequent pyroptosis following extended LPS priming. These suppressive glucocorticoid actions were associated with a marked expansion in the GR cistrome following LPS-mediated changes in the chromatin landscape. The glucocorticoid inhibition of the late NLRP3 inflammasome activation also was preserved in human monocyte-derived macrophages. The glucocorticoid effects were attenuated when LPS and glucocorticoids were added together, and they were largely absent in myeloid-GR knockout mice. This study, employing a glucocorticoid treatment regimen with clinically relevant timing, suggests an underlying metabolic mechanism by which glucocorticoids preserve the integrity of the TCA cycle and inhibit the glycolytic switch induced by LPS. The glucocorticoid regulation precedes the second signal for the NLRP3 inflammasome activation to strategically prevent hyperinflammation and pyroptosis in macrophages.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Internal Receptors
Surface Tension, Capillary Action, and Viscosity
The various IMFs between identical molecules of a substance are examples of cohesive forces. The molecules within a liquid are surrounded by other molecules and are attracted equally in all directions by the cohesive forces within the liquid. However, the molecules on the surface of a liquid are attracted only by about one-half as many molecules. Because of the unbalanced molecular attractions on the surface molecules, liquids contract to form a shape that minimizes the number...

